R E Champlin
Overview
Explore the profile of R E Champlin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
255
Citations
3948
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Srour S, Singh H, McCarty J, de Groot E, Huls H, Rondon G, et al.
Blood
. 2020 Jan;
135(11):862-865.
PMID: 31961918
No abstract available.
2.
Bachegowda L, Shah M, Veltri L, Tanase A, Popat U, Anderlini P, et al.
Bone Marrow Transplant
. 2017 Jul;
52(9):1347-1348.
PMID: 28692030
No abstract available.
3.
Kongtim P, Adekola K, Milton D, Ramlal R, Jimenez A, Chen J, et al.
Leukemia
. 2017 Apr;
31(7):1654-1657.
PMID: 28400618
No abstract available.
4.
Andersson B, Thall P, Valdez B, Milton D, Al-Atrash G, Chen J, et al.
Bone Marrow Transplant
. 2016 Dec;
52(4):580-587.
PMID: 27991894
We hypothesized that IV busulfan (Bu) dosing could be safely intensified through pharmacokinetic (PK-) dose guidance to minimize the inter-patient variability in systemic exposure (SE) associated with body-sized dosing, and...
5.
Qazilbash M, Wieder E, Thall P, Wang X, Rios R, Lu S, et al.
Leukemia
. 2016 Sep;
31(3):697-704.
PMID: 27654852
PR1, an HLA-A2-restricted peptide derived from both proteinase 3 and neutrophil elastase, is recognized on myeloid leukemia cells by cytotoxic T lymphocytes (CTLs) that preferentially kill leukemia and contribute to...
6.
Brammer J, Saliba R, Jorgensen J, Ledesma C, Gaballa S, Poon M, et al.
Bone Marrow Transplant
. 2016 Sep;
52(1):20-27.
PMID: 27618682
This study aims to provide a detailed analysis of allogeneic stem cell transplantation (allo-SCT) outcomes in a large T-cell acute lymphoblastic leukemia (T-ALL) cohort with a specific emphasis on the...
7.
Varma A, Saliba R, Torres H, Afrough A, Hosing C, Khouri I, et al.
Bone Marrow Transplant
. 2016 Mar;
51(7):999-1001.
PMID: 26950376
No abstract available.
8.
Shah J, Feng L, Thomas S, Berkova Z, Weber D, Wang M, et al.
Blood Cancer J
. 2016 Feb;
6:e396.
PMID: 26871714
The safety and efficacy of siltuximab (CNTO 328) was tested in combination with lenalidomide, bortezomib and dexamethasone (RVD) in patients with newly-diagnosed, previously untreated symptomatic multiple myeloma. Fourteen patients were...
9.
Abudayyeh A, Hamdi A, Lin H, Abdelrahim M, Rondon G, Andersson B, et al.
Am J Transplant
. 2015 Nov;
16(5):1492-502.
PMID: 26608093
Nephropathy due to BK virus (BKV) infection is an evolving challenge in patients undergoing hematopoietic stem cell transplantation (HSCT). We hypothesized that BKV infection was a marker of kidney function...
10.
Valdez B, Brammer J, Li Y, Murray D, Liu Y, Hosing C, et al.
Blood Cancer J
. 2015 Oct;
5:e357.
PMID: 26473529
Romidepsin is a cyclic molecule that inhibits histone deacetylases. It is Food and Drug Administration-approved for treatment of cutaneous and peripheral T-cell lymphoma, but its precise mechanism of action against...